Petrus Trust Company’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-66,025
Closed -$680K – 740
2024
Q2
$680K Buy
66,025
+20,575
+45% +$223K 0.06% 115
2024
Q1
$569K Buy
+45,450
New +$588K 0.05% 161
2019
Q2
– Sell
-8,752
Closed -$207K – 344
2019
Q1
$207K Buy
+8,752
New +$204K 0.04% 225
2017
Q4
– Sell
-13,191
Closed -$296K – 207
2017
Q3
$296K Buy
+13,191
New +$298K 0.07% 91
2016
Q3
– Sell
-10,993
Closed -$208K – 198
2016
Q2
$208K Buy
+10,993
New +$230K 0.05% 127

Other funds holding TBI

Petrus Trust Company's TBI Position: Q3 2024 in Review

Petrus Trust Company sold out of Trueblue (TBI) in Q3 2024, closing a stake of 66,025 shares — an estimated $680K sold.

Petrus Trust Company first reported a position in TBI in Q2 2016 and held it in 5 quarters. The position peaked at $680K in Q2 2024. 112 funds tracked by Wall St. Rank hold TBI as of Q3 2024.

  • Petrus Trust Company reported no remaining Trueblue position as of Q3 2024 after selling out during the quarter.
  • Petrus Trust Company sold 66,025 Trueblue shares in Q3 2024, an estimated $680K.
  • Petrus Trust Company first reported a position in Trueblue in Q2 2016 and held it in 5 quarters.
  • Petrus Trust Company's Trueblue position peaked at $680K in Q2 2024.
  • 112 funds tracked by Wall St. Rank held Trueblue as of Q3 2024.

Based on Petrus Trust Company's 13F filing for Q3 2024, filed 14 Nov 2024.